6. Parkinson disease Clinical trials / Disease details

Clinical trials : 2,298 / Drugs : 2,202 - (DrugBank : 350) / Drug target genes : 188 - Drug target pathways : 202

3 trials found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2007-002874-75-IT (EUCTR)	10/09/2007	14/01/2008	Safety and effectivness of Open- Label Melperone in the treatment of Patients with Psycosis Associated with Parkinson's Disease'' - OV-1005	Safety and effectivness of Open- Label Melperone in the treatment of Patients with Psycosis Associated with Parkinson's Disease'' - OV-1005	Psycosis associated to Parkinson's Disease MedDRA version: 9.1;Level: HLT;Classification code 10027361;Term: Mental disorders due to a general medical condition NEC	Product Name: Melperon	OVATION PHARMACEUTICALS INC	NULL	Not Recruiting			Female: yes Male: yes	90		Italy
2	EUCTR2007-000307-15-IT (EUCTR)	24/04/2007	23/08/2007	Safety and Efficacy of Melperone in the Treatment of Patients with Psychosis Associated with Parkinson's Disease.	Safety and Efficacy of Melperone in the Treatment of Patients with Psychosis Associated with Parkinson's Disease.	Psicosi associata al morbo di Parkinson MedDRA version: 9.1;Level: LLT;Classification code 10013113;Term: Disease Parkinson's	Product Name: Melperon INN or Proposed INN: melperon	OVATION PHARMACEUTICALS INC	NULL	Not Recruiting			Female: yes Male: yes	90		Italy
3	NCT00125138 (ClinicalTrials.gov)	July 2005	27/7/2005	Melperone (an Anti-Psychotic) in Patients With Psychosis Associated With Parkinson's Disease	Safety and Efficacy of Melperone in the Treatment of Patients With Psychosis Associated With Parkinson's Disease	Parkinson's Disease;Psychotic Disorders	Drug: Melperone HCl;Drug: Placebo	Lundbeck LLC	NULL	Completed	N/A	N/A	All	90	Phase 2	United States;India;Italy